-
1
-
-
85013312416
-
Tumor angiogenesis: Therapeutic implications
-
Folkman J (1971) Tumor angiogenesis: Therapeutic implications. N Engl J Med 285:1182-1186
-
(1971)
N Engl J Med
, vol.285
, pp. 1182-1186
-
-
Folkman, J.1
-
2
-
-
0036842215
-
Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy
-
Dvorak HF (2002) Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 20:4368-4380
-
(2002)
J Clin Oncol
, vol.20
, pp. 4368-4380
-
-
Dvorak, H.F.1
-
3
-
-
0036985699
-
Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implications
-
Ferrara N (2002) Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implications. Semin Oncol 29:10-14
-
(2002)
Semin Oncol
, vol.29
, pp. 10-14
-
-
Ferrara, N.1
-
4
-
-
33344474964
-
Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis
-
Shibuya M, Claesson-Welsh L (2006) Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 312:549-560
-
(2006)
Exp Cell Res
, vol.312
, pp. 549-560
-
-
Shibuya, M.1
Claesson-Welsh, L.2
-
5
-
-
0021111648
-
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
-
Senger DR, Galli SJ, Dvorak AM et al (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985
-
(1983)
Science
, vol.219
, pp. 983-985
-
-
Senger, D.R.1
Galli, S.J.2
Dvorak, A.M.3
-
6
-
-
3042548695
-
Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts
-
Inai T, Mancuso M, Hashizume H et al (2004) Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Path 165:35-52
-
(2004)
Am J Path
, vol.165
, pp. 35-52
-
-
Inai, T.1
Mancuso, M.2
Hashizume, H.3
-
7
-
-
0027197245
-
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
-
Kim KJ, Li B, Winer J et al (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841-844
-
(1993)
Nature
, vol.362
, pp. 841-844
-
-
Kim, K.J.1
Li, B.2
Winer, J.3
-
8
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
-
Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342
-
(2004)
N Engl J Med
, vol.350
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
-
9
-
-
41149138113
-
Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer
-
Jain RK (2008) Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer. Nat Rev Cancer 8:309-316
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 309-316
-
-
Jain, R.K.1
-
10
-
-
79551559952
-
Bevacizumab treatment for solid tumors: Boon or bust?
-
Hayes DF (2011) Bevacizumab treatment for solid tumors: Boon or bust? J Am Med Assoc 305:506-508
-
(2011)
J Am Med Assoc
, vol.305
, pp. 506-508
-
-
Hayes, D.F.1
-
12
-
-
55449108272
-
Tumor blood vessels. Structure, function and classification
-
Teicher BA, Ellis LM (eds). Humana Press, Totowa
-
Fu Y, Nagy JA, Dvorak AM et al (2007) Tumor blood vessels. Structure, function and classification. In: Teicher BA, Ellis LM (eds) Cancer drug discovery and development antiangiogenic agents in cancer therapy. Humana Press, Totowa, pp 205-224
-
(2007)
Cancer Drug Discovery and Development Antiangiogenic Agents in Cancer Therapy
, pp. 205-224
-
-
Fu, Y.1
Nagy, J.A.2
Dvorak, A.M.3
-
14
-
-
33947414473
-
VEGF-A and the induction of pathological angiogenesis
-
Nagy JA, Dvorak AM, Dvorak HF (2007) VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol 2: 251-275
-
(2007)
Annu Rev Pathol
, vol.2
, pp. 251-275
-
-
Nagy, J.A.1
Dvorak, A.M.2
Dvorak, H.F.3
-
15
-
-
17344390961
-
Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor
-
Pettersson A, Nagy JA, Brown LF et al (2000) Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest 80:99-115
-
(2000)
Lab Invest
, vol.80
, pp. 99-115
-
-
Pettersson, A.1
Nagy, J.A.2
Brown, L.F.3
-
16
-
-
0025994605
-
First steps of tumor-related angiogenesis
-
Paku S, Paweletz N (1991) First steps of tumor-related angiogenesis. Lab Invest 65:334-346
-
(1991)
Lab Invest
, vol.65
, pp. 334-346
-
-
Paku, S.1
Paweletz, N.2
-
17
-
-
66249098899
-
VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation
-
Chang SH, Kanasaki K, Gocheva V et al (2009) VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation. Cancer Res 69:4537-4544
-
(2009)
Cancer Res
, vol.69
, pp. 4537-4544
-
-
Chang, S.H.1
Kanasaki, K.2
Gocheva, V.3
-
18
-
-
0024615091
-
Distensibility of single capillaries and venules in the rat and frog mesentery
-
Swayne GT, Smaje LH, Bergel DH (1989) Distensibility of single capillaries and venules in the rat and frog mesentery. Int J Microcirc Clin Exp 8:25-42
-
(1989)
Int J Microcirc Clin Exp
, vol.8
, pp. 25-42
-
-
Swayne, G.T.1
Smaje, L.H.2
Bergel, D.H.3
-
19
-
-
0030045180
-
The vesiculo-vacuolar organelle (VVO): A distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation
-
Dvorak AM, Kohn S, Morgan ES et al (1996) The vesiculo-vacuolar organelle (VVO): A distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukoc Biol 59:100-115
-
(1996)
J Leukoc Biol
, vol.59
, pp. 100-115
-
-
Dvorak, A.M.1
Kohn, S.2
Morgan, E.S.3
-
20
-
-
0029890824
-
Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin
-
Feng D, Nagy JA, Hipp J et al (1996) Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med 183:1981-1986
-
(1996)
J Exp Med
, vol.183
, pp. 1981-1986
-
-
Feng, D.1
Nagy, J.A.2
Hipp, J.3
-
21
-
-
33746257413
-
Permeability properties of tumor surrogate blood vessels induced by VEGF-A
-
Nagy JA, Feng D, Vasile E et al (2006) Permeability properties of tumor surrogate blood vessels induced by VEGF-A. Lab Invest 86:767-780
-
(2006)
Lab Invest
, vol.86
, pp. 767-780
-
-
Nagy, J.A.1
Feng, D.2
Vasile, E.3
-
22
-
-
0035106147
-
Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery
-
Sundberg C, Nagy JA, Brown LF et al (2001) Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol 158:1145-1160
-
(2001)
Am J Pathol
, vol.158
, pp. 1145-1160
-
-
Sundberg, C.1
Nagy, J.A.2
Brown, L.F.3
-
23
-
-
47949099628
-
Modes of resistance to antiangiogenic therapy
-
Bergers G, Hanahan D (2008) Modes of resistance to antiangiogenic therapy. Nat Rev Cancer 8:592-603
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 592-603
-
-
Bergers, G.1
Hanahan, D.2
-
24
-
-
79957894276
-
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
-
Carmeliet P, Jain RK (2011) Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discovery 10:417-427
-
(2011)
Nat Rev Drug Discovery
, vol.10
, pp. 417-427
-
-
Carmeliet, P.1
Jain, R.K.2
-
25
-
-
77951498489
-
Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis
-
Ferrara N (2010) Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis. Curr Opin Hematol 17:219-224
-
(2010)
Curr Opin Hematol
, vol.17
, pp. 219-224
-
-
Ferrara, N.1
-
26
-
-
0038476608
-
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
-
Bergers G, Song S, Meyer-Morse N et al (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111:1287-1295
-
(2003)
J Clin Invest
, vol.111
, pp. 1287-1295
-
-
Bergers, G.1
Song, S.2
Meyer-Morse, N.3
-
27
-
-
84860130221
-
Anti-VEGFVEGFR therapy for cancer: Reassessing the target
-
Sitohy B, Nagy J, Dvorak H (2012) Anti-VEGF/VEGFR therapy for cancer: Reassessing the target. Cancer Res 72:1909-1914
-
(2012)
Cancer Res
, vol.72
, pp. 1909-1914
-
-
Sitohy, B.1
Nagy, J.2
Dvorak, H.3
-
28
-
-
81155132190
-
Tumor surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy
-
Sitohy B, Nagy J, Jaminet S-C et al (2011) Tumor surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy. Cancer Res 71:7021-7028
-
(2011)
Cancer Res
, vol.71
, pp. 7021-7028
-
-
Sitohy, B.1
Nagy, J.2
Jaminet, S.-C.3
-
29
-
-
68149169793
-
Rapamycin inhibition of the Akt/mTOR pathway blocks select stages of VEGF-A164-driven angiogenesis, in part by blocking S6Kinase
-
Xue Q, Nagy JA, Manseau EJ et al (2009) Rapamycin inhibition of the Akt/mTOR pathway blocks select stages of VEGF-A164-driven angiogenesis, in part by blocking S6Kinase. Arterioscler Thromb Vasc Biol 29:1172-1178
-
(2009)
Arterioscler Thromb Vasc Biol
, vol.29
, pp. 1172-1178
-
-
Xue, Q.1
Nagy, J.A.2
Manseau, E.J.3
-
30
-
-
0037143764
-
VEGF-Trap: A VEGF blocker with potent antitumor effects
-
Holash J, Davis S, Papadopoulos N et al (2002) VEGF-Trap: A VEGF blocker with potent antitumor effects. Proc Natl Acad Sci USA 99:11393-11398
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 11393-11398
-
-
Holash, J.1
Davis, S.2
Papadopoulos, N.3
-
31
-
-
0034682892
-
Genes expressed in human tumor endothelium
-
St Croix B, Rago C, Velculescu V et al (2000) Genes expressed in human tumor endothelium. Science 289:1197-1202
-
(2000)
Science
, vol.289
, pp. 1197-1202
-
-
St Croix, B.1
Rago, C.2
Velculescu, V.3
|